These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7813816)

  • 1. A novel insulin secretagogue is a phosphodiesterase inhibitor.
    Leibowitz MD; Biswas C; Brady EJ; Conti M; Cullinan CA; Hayes NS; Manganiello VC; Saperstein R; Wang LH; Zafian PT
    Diabetes; 1995 Jan; 44(1):67-74. PubMed ID: 7813816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
    Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
    Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type VIII adenylyl cyclase in rat beta cells: coincidence signal detector/generator for glucose and GLP-1.
    Delmeire D; Flamez D; Hinke SA; Cali JJ; Pipeleers D; Schuit F
    Diabetologia; 2003 Oct; 46(10):1383-93. PubMed ID: 13680124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway.
    Lee JW; Swick AG; Romsos DR
    Exp Biol Med (Maywood); 2003 Feb; 228(2):175-82. PubMed ID: 12563024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
    Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
    Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
    Miura Y; Matsui H
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of GLP-I and leptin at rat pancreatic B-cells: effects on insulin secretion and signal transduction.
    Fehmann HC; Bode HP; Ebert T; Karl A; Göke B
    Horm Metab Res; 1997 Nov; 29(11):572-6. PubMed ID: 9479558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose dependence of insulinotropic actions of pituitary adenylate cyclase-activating polypeptide in insulin-secreting INS-1 cells.
    Rosengren A; Filipsson K; Jing XJ; Reimer MK; Renström E
    Pflugers Arch; 2002 Jul; 444(4):556-67. PubMed ID: 12136276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid.
    Green BD; Gault VA; Flatt PR; Harriott P; Greer B; O'Harte FP
    Arch Biochem Biophys; 2004 Aug; 428(2):136-43. PubMed ID: 15246869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.
    Islam MS; Rahman SA; Mirzaei Z; Islam KB
    Life Sci; 2005 Jan; 76(11):1239-48. PubMed ID: 15642594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse pancreatic beta-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene.
    Flamez D; Van Breusegem A; Scrocchi LA; Quartier E; Pipeleers D; Drucker DJ; Schuit F
    Diabetes; 1998 Apr; 47(4):646-52. PubMed ID: 9568699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
    Gromada J; Dissing S; Bokvist K; Renström E; Frøkjaer-Jensen J; Wulff BS; Rorsman P
    Diabetes; 1995 Jul; 44(7):767-74. PubMed ID: 7789644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
    Montrose-Rafizadeh C; Egan JM; Roth J
    Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin inhibits glucagon-like peptide-1-induced insulin secretion and proliferation of RINm5F insulinoma cells.
    Stark A; Mentlein R
    Regul Pept; 2002 Oct; 108(2-3):97-102. PubMed ID: 12220732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells.
    Morgan DG; Kulkarni RN; Hurley JD; Wang ZL; Wang RM; Ghatei MA; Karlsen AE; Bloom SR; Smith DM
    Diabetologia; 1998 Dec; 41(12):1482-91. PubMed ID: 9867216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
    Jehle PM; Jehle D; Fussgänger RD; Adler G
    Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.